Welcome to Week 4 of Oktober-TEST, SPL’s October series highlighting the specialty methods our laboratories run and the technical teams behind them. We started with heavy-end crude and condensate analysis by GPA 2103, moved to Whole Effluent Toxicity testing at our Conroe lab, and followed with LNG feed gas analysis. This week we’re closing the series in Reading, Pennsylvania, with a look at PFAS treatment verification: how consultants, facility teams, and utilities can build sampling plans and choose lab methods so their treatment data holds up to agency review.
Key Points
- The federal MCLs for PFOA and PFOS in drinking water are 4.0 parts per trillion (ppt). That is also EPA’s practical quantitation level, so a result near the limit depends on the lab’s reporting limit and quality control.
- The trigger level for reduced drinking water monitoring is half the MCL, or 2.0 ppt, so a lab needs to report reliably below that number.
- Drinking water compliance is based on a running annual average. A single clean sample shows treatment performance, not compliance.
- Short-chain PFAS usually break through treatment media first. EPA Method 537.1 does not measure PFBA or PFPeA, while Methods 533 and 1633 do.
- SPL’s Reading, Pennsylvania laboratory runs EPA Methods 533, 537.1 and 1633 under NELAP accreditation, and SPL performed drinking water PFAS analysis for UCMR 5.
PFAS treatment is moving from pilot to full scale. Regenerable ion exchange, granular activated carbon, foam fractionation and destruction technologies are all treating real water at real sites, and providers are publishing results that say treated water meets federal limits.

Every one of those results ends in the same place: a laboratory report. The treatment system removes the PFAS. The lab result is what shows that it did, and whether that result holds up depends on decisions made long before the first sample reaches the lab.
If you need a refresher on how EPA Methods 533, 537.1, and 1633 differ, start with our comparison of the three PFAS methods. This article covers the next step: designing verification sampling so the data support the claim you need to make.
Know Which Claim You’re Making
PFAS treatment data usually supports one of four claims, and each one answers to a different set of rules.
- Treatment performance: Is the system removing PFAS as designed? This is an engineering question, typically answered with influent, midpoint and effluent sampling.
- Remediation progress: Is the site cleanup on track? The regulator and the project’s QAPP usually set the method, often EPA Method 1633 for groundwater and soil.
- Discharge compliance: Does treated water meet a permit limit? The permit and the governing program decide the method and frequency.
- Drinking water compliance: Does a public water system meet the MCL? This requires EPA Method 533 or 537.1, a state-certified lab, and the monitoring schedule set by the Safe Drinking Water Act.
A system can produce good numbers for one claim that don’t count toward another. Naming the claim at the start keeps the sampling plan, the method and the final report aligned.
Set Reporting Limits Below the Decision Point
EPA set the PFOA and PFOS MCLs at 4.0 ppt, the same level as its practical quantitation level. In other words, the regulatory limit sits right at the edge of what labs can reliably quantify. A result reported near 4 ppt is only as strong as the reporting limit, calibration, and blank performance behind it.
The rule adds a second threshold. Systems with initial results below the trigger level of 2.0 ppt can qualify for reduced monitoring. Data that can’t reliably show results below 2.0 ppt can’t support that decision.
Before sampling begins, ask your lab:
- What is your reporting limit for PFOA and PFOS?
- How are field blanks and method blanks handled and reported
- Which accreditation covers this method and matrix in my state?
These answers belong in the sampling plan, not in a follow-up email after the results come back.
Design Sampling Around Breakthrough
Most treatment systems lose short-chain PFAS before long-chain compounds. Carbon and ion exchange media hold molecules such as PFOA and PFOS longer, while smaller compounds such as PFBA and PFBS move through sooner. Early breakthrough is usually a short-chain story.
That makes method choice part of system design. EPA Method 537.1 does not measure PFBA or PFPeA. Methods 533 and 1633 do. A monitoring program built only on 537.1 can miss the first sign that media is reaching capacity.

A typical verification sampling design includes:
- Raw water to establish the PFAS profile entering the system
- Midpoint between lead and lag vessels to detect breakthrough before it reaches the effluent
- Entry point to document treated water quality
- Before-and-after checks when media is replaced or regenerated, to confirm performance returns to baseline
Sampling frequency usually runs higher during startup and after any media change, then settles into a routine schedule once the system has a record.
One Result Isn’t a Compliance Record
A single effluent result below 4.0 ppt is good news for treatment performance. It is not, on its own, a compliance determination. Drinking water compliance with the PFAS MCLs is calculated as a running annual average of samples at each entry point, collected on the schedule the rule requires.
Treatment performance reports and compliance records can both be accurate. They answer different questions. When documentation keeps them separate, regulators, utility boards and the public can trust both.
Keep the Record Defensible
Verification data is only as strong as the record behind it. PFAS sampling has a few specific requirements:
- Use PFAS-free sampling materials provided by your laboratory. Some waterproof clothing, sunscreens and sampling gear contain fluoropolymers that show up in results.
- Collect field blanks so any contamination can be identified rather than argued about.
- Follow each method’s container, preservation and holding time requirements.
- Maintain an unbroken chain of custody from collection to final report.
- Consider split samples on high-visibility projects so a second dataset is available if results are questioned.
Our free environmental sampling guide covers PFAS contamination control, chain of custody documentation and a field-ready checklist.
PFAS Treatment Verification From Reading and Commerce City
SPL’s Reading, Pennsylvania laboratory runs EPA Methods 533, 537.1 and 1633 under NELAP accreditation, and SPL Commerce City runs Method 533. SPL also performed drinking water PFAS analysis for UCMR 5. One laboratory can support influent characterization, breakthrough monitoring and drinking water compliance under one quality system and one chain of custody. 
Reading sits within a short drive of active PFAS hot spot projects across Montgomery, Bucks and Chester Counties Pennsylvania, and clients across the country ship samples to the lab every week. Rich Stump, SVP of SPL’s Environmental Division, leads a technical team that helps consultants and facility teams set methods, reporting limits and sampling plans before the first bottle ships.
Treatment gets PFAS out of the water. Defensible data shows it worked.
Frequently Asked Questions
What is PFAS treatment verification?
PFAS treatment verification is the laboratory testing that confirms a treatment system is removing PFAS as intended. It typically includes influent, midpoint and effluent sampling, analyzed by an accredited lab using an EPA method suited to the sample matrix. Verification data can support treatment performance claims, remediation progress reports, discharge permits or drinking water compliance, and each of those uses has its own method and sampling requirements.
How often should a PFAS treatment system be sampled?
It depends on the system and the claim the data supports. Sampling is usually more frequent during startup and after any media change or regeneration, then moves to a routine schedule once performance is established. Drinking water compliance follows the monitoring schedule in the federal PFAS rule and any state requirements. Permits and remediation QAPPs set their own frequencies.
Which EPA method should be used to monitor PFAS breakthrough?
Methods that measure short-chain PFAS are best suited for breakthrough monitoring, because short-chain compounds usually pass through treatment media first. EPA Methods 533 and 1633 include PFBA and PFPeA. EPA Method 537.1 does not. For drinking water, Method 533 is commonly used. For groundwater, wastewater and other non-potable matrices, Method 1633 is the EPA-validated option.
Does one effluent sample below 4 ppt mean a system meets the PFAS MCL?
No. A single result below 4.0 ppt shows good treatment performance, but drinking water compliance with the PFOA and PFOS MCLs is calculated as a running annual average of samples collected at each entry point on the schedule the rule requires. Treatment performance data and compliance records answer different questions and should be documented separately.
What reporting limit should a lab achieve for PFAS treatment monitoring?
For PFOA and PFOS, ask for reporting limits below 2.0 ppt. The MCL is 4.0 ppt, and the trigger level for reduced drinking water monitoring is half that. A lab that can reliably report below 2.0 ppt can support both compliance and reduced monitoring decisions. Confirm the reporting limit, blank handling and accreditation for your matrix before sampling begins.
Is SPL accredited for PFAS treatment monitoring?
Yes. SPL’s Reading, Pennsylvania laboratory holds NELAP accreditation for EPA Methods 533, 537.1 and 1633, and SPL Commerce City is accredited for Method 533. SPL also performed drinking water PFAS analysis for UCMR 5. Contact SPL to confirm accreditation for your specific matrix and state program before sampling.
Plan Your Verification Sampling
Tell us what your treatment system needs to prove, and our PFAS team will recommend the method, reporting limits and sampling plan to support it.